Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

Clinical trial NCT01812252 · COMPLETED

Trial details

NCT number: NCT01812252
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome

Start date: 2013-08-19
Primary completion: 2022-10-26
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.